Methotrexate - Centre of Research Excellence in Pulmonary Fibrosis

This resource provides information about the immunosuppressant medication methotrexate (Methoblastin, ARX-Methotrexate, Chexate), including how it works, why it is recommended and common side effects.

Methotrexate Face Sheet OYO251126_Methotrexate-Fact-Sheet_Digital.pdf

Pulmonary Fibrosis Institute

The Centre of Research Excellence in Pulmonary Fibrosis has established the Pulmonary Fibrosis Institute, a not-for-profit company registered in Australia. The Pulmonary Fibrosis Institute exists to support ongoing research into pulmonary fibrosis and ensure the longevity of research infrastructure developed through our collaborative efforts.